Document is current
Any future updates will be listed below
-
Authors
Nijssen, Klaartje
Westinga, Kasper
Stuut, Anniek
Janssen, Anke
van Rhenen, Anna
van der Wagen, Lotte
Daenen, Laura G. M.
Oostvogels, Rimke
de Witte, Moniek A.
Kuball, Jürgen https://orcid.org/0000-0002-3914-7806
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (2015-7553, 2021-13493)
Miltenyi Biotec
- License Information
-
More Information
Article History
Received: 21 November 2022
Revised: 20 March 2023
Accepted: 22 March 2023
First Online: 3 April 2023
Competing interests
: JK is inventor on multiple patents dealing with gdTCRs, ligands, isolation strategies of engineered immune cells. JK is cofounder and shareholder of Gadeta (). JK and MdW received research, advisor and clinical study support from Miltenyi Biotech. JK received further research support from Novartis and Gadeta.
Free to read: This content has been made available to all.
